Appelbaum Fr
Impact in
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Mesenchymal stem cell research
Papers in
- Hematology 39
- Hematopoietic Stem Cell Transplantation 30
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 4
- Genetics 12
- Mesenchymal stem cell research 7
- Co-authors
- CD Buckner (28 shared papers)Rainer Storb (21 shared papers)JE Sanders (12 shared papers)K Doney (12 shared papers)Clift Ra (12 shared papers)Thomas Ed (10 shared papers)Deeg Hj (10 shared papers)A Fefer (5 shared papers)
- Journals
- Cancer Research (1 paper)Experimental Hematology (1 paper)PubMed (59 papers)
- Partner nations
- United StatesSouth Africa
In The Last Decade
Appelbaum Fr
61 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 84
- Hematology 1.3k
- Genetics 213
- Oncology 477
- Transplantation 45
- Immunology 286
Countries citing papers authored by Appelbaum Fr
This map shows the geographic impact of Appelbaum Fr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Appelbaum Fr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Appelbaum Fr more than expected).
Fields of papers citing papers by Appelbaum Fr
This network shows the impact of papers produced by Appelbaum Fr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Appelbaum Fr. The network helps show where Appelbaum Fr may publish in the future.
Co-authors
The 25 scholars most cited alongside Appelbaum Fr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. | 1987 | 165 |
| 2 | Late complications after marrow transplantation. | 1984 | 111 |
| 3 | Marrow transplantation for aplastic anemia. | 1984 | 109 |
| 4 | Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. | 1991 | 97 |
| 5 | A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. | 1996 | 97 |
| 6 | Allogeneic hematopoietic stem cell transplantation for acute leukemia. | 1997 | 77 |
| 7 | Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. | 1990 | 62 |
| 8 | Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation. | 1995 | 53 |
| 9 | Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung. | 1983 | 52 |
| 10 | Antibody-targeted therapy for myeloid leukemia. | 1999 | 49 |
| 11 | Changing trends in marrow transplantation for aplastic anemia. | 1992 | 46 |
| 12 | Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL). | 1997 | 46 |
| 13 | Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. | 1989 | 45 |
| 14 | Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia. | 1996 | 41 |
| 15 | The pathogenesis of aplastic anemia. | 1981 | 39 |
| 16 | Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody. | 1992 | 37 |
| 17 | Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia. | 1994 | 36 |
| 18 | Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. | 1987 | 35 |
| 19 | Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission. | 1987 | 34 |
| 20 | Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. | 1995 | 34 |
About Appelbaum Fr
Appelbaum Fr is a scholar working on Hematology, Genetics, Oncology, Public Health, Environmental and Occupational Health and Surgery, having authored 61 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (30 papers), Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (9 papers), Mesenchymal stem cell research (7 papers), Hematological disorders and diagnostics (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Transplantation: Methods and Outcomes (4 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (213 citations), Oncology (477 citations), Transplantation (45 citations) and Immunology (286 citations). Appelbaum Fr has collaborated with scholars based in United States and South Africa. Frequent co-authors include CD Buckner, Rainer Storb, JE Sanders, K Doney, Clift Ra, Thomas Ed, Deeg Hj, A Fefer, Petersen Fb and Jack W. Singer. Their work appears in journals such as Cancer Research, Experimental Hematology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.